Information  X 
Enter a valid email address

Compagnie St-Gobain (COD)

  Print      Mail a friend

Tuesday 31 July, 2018

Compagnie St-Gobain

Divestment

RNS Number : 3806W
Compagnie de Saint-Gobain
31 July 2018
 

PRESS RELEASE

 

July 31, 2018

 

Saint-Gobain divests its Glazing Installation business

in the United Kingdom

 

 

Following a strategic review of its British glass business, Saint-Gobain has sold, effective August 1st 2018, its façade installing and glass replacing activities in the United Kingdom (UK), to an affiliate of CoBe Capital.

 

Trading under the Glassolutions name until the disposal, this business has delivered an annual turnover around £70m, and employs around 440 people.

 

The rest of the Glassolutions activities, in the core areas of glass transformation and distribution for new construction and renovation, are not affected by this move.

 

The disposal is part of the Group target to focus on a coherent and value-creating portfolio of businesses.

 

 

ABOUT SAINT-GOBAIN

Saint-Gobain designs, manufactures and distributes materials and solutions which are key ingredients in the wellbeing of each of us and the future of all. They can be found everywhere in our living places and our daily life: in buildings, transportation, infrastructure and in many industrial applications. They provide comfort, performance and safety while addressing the challenges of sustainable construction, resource efficiency and climate change.

 

€40.8 billion in sales in 2017

Operates in 67 countries

More than 179,000 employees

www.saint-gobain.com 
@saintgobain

 

 

 

Analyst/Investor relations

 

 

Media relations

Vivien Dardel

Floriana Michalowska

Christelle Gannage

 +33 1 47 62 44 29

 +33 1 47 62 35 98

 +33 1 47 62 30 93

Laurence Pernot

Susanne Trabitzsch

 +33 1 47 62 30 10

 +33 1 47 62 43 25

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCEAKXFDAEPEFF

a d v e r t i s e m e n t